Coronavirus disease 2019-associated pulmonary fibrosis: clinical findings, pathogenesis, and potential treatment.

Jiang, Ya-Le; Dai, Hua-Ping; Wang, Chen

Jiang, Ya-Le; Dai, Hua-Ping; Wang, Chen.

Jiang YL; School of Medicine, Tsinghua University, Beijing 100084, China.
Dai HP; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Disease, Beijing 100029, China.
Wang C; Department of Pulmonary and Critical Care Medicine, China-Japan Friendship Hospital, National Center for Respiratory Medicine, Institute of Respiratory Medicine, Chinese Academy of Medical Sciences, National Clinical Research Center for Respiratory Disease, Beijing 100029, China.

Chin Med J (Engl) ; 134(15): 1792-1794, 2021 Aug 05.

Article in English | MEDLINE | ID: covidwho-1769419

Subject(s)

COVID-19; Idiopathic Pulmonary Fibrosis; Pulmonary Fibrosis; Humans; SARS-CoV-2

Fulltext

XML

PubMed Links

Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: Pulmonary Fibrosis / Idiopathic Pulmonary Fibrosis / COVID-19 Type of study: Prognostic study Limits: Humans Language: English Journal: Chin Med J (Engl) Year: 2021 Document Type: Article Affiliation country: CM9.0000000000001464

Similar

MEDLINE

LILACS

LIS

Fulltext

XML

PubMed Links

Search on Google